Codes / ICD10CM / M05.27

M05.27 Rheumatoid vasculitis with rheumatoid arthritis of ankle and foot

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Rheumatoid vasculitis with rheumatoid arthritis of ankle and foot

Summary

Rheumatoid vasculitis with rheumatoid arthritis of ankle and foot is a localized complication of rheumatoid arthritis (RA) involving inflammation of blood vessels in the ankle and foot regions. It occurs when the systemic immune dysregulation of RA affects vascular structures, potentially leading to tissue damage or functional impairment in these areas. This condition reflects the localized impact of RA’s inflammatory processes on specific anatomical sites.

Causes

The exact cause of rheumatoid vasculitis is not fully understood. It is believed to result from chronic inflammation and immune dysregulation associated with rheumatoid arthritis, leading to vascular damage. Autoantibodies, immune complexes, and inflammatory cytokines may contribute to vessel inflammation, though the precise mechanisms remain under investigation.

Risk Factors

  • Long-standing, severe rheumatoid arthritis
  • High disease activity or titers of rheumatoid factor (RF) or anti-citrullinated protein antibodies (ACPA)
  • Presence of subcutaneous nodules
  • Male gender
  • Older age

Symptoms

  • Ankle or foot pain, stiffness, or swelling
  • Skin manifestations (e.g., purpura, ulcers, or nodules) in the ankle or foot area
  • Peripheral neuropathy affecting the ankle or foot
  • Systemic symptoms (e.g., fever, weight loss, fatigue)
  • Joint pain and swelling from underlying rheumatoid arthritis

Diagnosis

Diagnosis involves a combination of clinical evaluation, laboratory tests, and imaging. Clinical assessment focuses on identifying vasculitis-related symptoms in the ankle or foot, along with signs of RA. Laboratory tests may include inflammatory markers, autoantibodies (e.g., RF, ACPA), and vascular imaging (e.g., Doppler ultrasound, MRI) to detect vessel inflammation. Biopsy of affected tissue may be performed to confirm vasculitis. Differential diagnosis excludes other causes of ankle/foot inflammation, such as infection or other vasculitides.

Treatment Options

Treatment targets both the underlying rheumatoid arthritis and the vasculitis. RA management typically involves disease-modifying antirheumatic drugs (DMARDs), biologic agents, or corticosteroids to reduce systemic inflammation. Vasculitis-specific therapy may include immunosuppressants (e.g., cyclophosphamide) or high-dose corticosteroids. Localized symptoms (e.g., pain, swelling) may be managed with NSAIDs, physical therapy, or supportive care. Treatment plans are individualized based on disease severity and organ involvement.

Prognosis and Follow-Up

Prognosis depends on the extent of vascular involvement and response to treatment. Early intervention with effective RA control can improve outcomes. Regular follow-up is essential to monitor disease activity, adjust therapy, and detect complications (e.g., tissue necrosis, infection). Long-term management focuses on maintaining remission and preventing relapse.

Complications

  • Tissue necrosis or ulceration in the ankle or foot
  • Peripheral neuropathy leading to numbness or weakness
  • Secondary infections of skin lesions
  • Impaired mobility or functional disability
  • Systemic spread of vasculitis affecting other organs

Lifestyle & Prevention

  • Optimize RA management to reduce disease activity and vasculitis risk.
  • Avoid smoking, which exacerbates RA and vascular inflammation.
  • Maintain a healthy weight and regular exercise to support joint and vascular health.
  • Protect feet and ankles from injury to prevent complications.
  • Monitor for early signs of vasculitis (e.g., skin changes, pain) and report promptly.

When to Seek Professional Help

Seek medical attention if you experience:

  • Sudden or worsening ankle/foot pain, swelling, or discoloration.
  • Skin ulcers, nodules, or non-healing sores in the ankle or foot.
  • Numbness, tingling, or weakness in the foot or ankle.
  • Systemic symptoms (fever, fatigue, unexplained weight loss).
  • Signs of infection (e.g., redness, warmth, pus) in affected areas.

Tips for Medical Coders

Document the presence of rheumatoid vasculitis and its specific location (ankle and foot) to support accurate coding. Include details on RA activity, vascular involvement, and any associated symptoms or complications. Ensure documentation aligns with clinical findings to justify the use of M05.27. Verify that the code is not used for vasculitis without RA or for RA without vasculitis.

Book a walkthrough

M05.27 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.